Non-invasive Drug, Protein and Gene Delivery Systems: Current Progress and Future Prospects
A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Nanomedicine and Nanotechnology".
Deadline for manuscript submissions: closed (28 February 2021) | Viewed by 5244
Special Issue Editor
Special Issue Information
Dear Colleagues,
It is with great delight and honor to invite you to contribute to the upcoming Special Issue of Pharmaceutics on “Non-invasive Drug, Protein and Gene Delivery Systems: Current Progress and Future Prospects”.
This issue will be a collection of frontier research papers focusing on exploring the newest knowledge, research and translation in non-invasive approaches related to
- pharmaceutical, chemical, physicochemical and biophysical non-invasive technologies for improved therapies, diagnostics and imaging in all clinical areas of application
- needle-free administration methods using novel dosage forms, nanotechnology and devices
- research on dermal, transdermal, pulmonary, ocular, otic, vaginal, rectal, buccal and oral administration methods and potential solutions to the challenges of the barriers in these routes of administration
- non-invasive delivery systems for small molecules, proteins, peptides, DNA, RNA and vaccines
- critical appraisals and comparisons of benefits and reliability of non-invasive technologies, including modelling and simulation approaches
- evaluation of patient benefits of non-invasive technologies in hospital and home settings
The deadline for contribution of either a research paper or a review article to this Special Issue will be by 31 October 2020.
At this time, if you are interested, please send me the tentative title of the article and a short outline of the scope of the paper, and any questions you may have.
I hope that you will accept the invitation to be part of this exciting Special Issue.
Prof. Marianna Foldvari
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- non-invasive drug delivery
- needle-free
- pharmaceutical
- small molecule drugs
- proteins and peptides
- nucleic acids
- vaccines
- nanomedicine
- dosage forms
- devices
